Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
62
HALO Quote, Financials, Valuation and Earnings
Last price:
$57.79
Seasonality move
:
-2.44%
Day range:
$57.57 - $58.56
52-week range:
$42.01 - $70.51
Dividend yield:
0%
P/E ratio:
15.37x
P/S ratio:
6.87x
P/B ratio:
14.77x
Volume:
1.1M
Avg. volume:
2.4M
1-year change:
5.58%
Market cap:
$7.1B
Revenue:
$1B
EPS (TTM):
$3.76
Earnings Data
Next earnings date for HALO
Aug 06
2025
Most recent earnings per share
$0.93
Missed by $0.01
(May 6/2025)
Consensus Estimate
$0.94
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HALO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $330.9M | -- | -- | $1.44 | -- |
| 08/06/2025 | Q2 | $285.9M | -- | -- | $1.23 | -- |
| 05/06/2025 | Q1 | $230.2M | $264.9M | $0.93 | $0.94 | -$0.01 |
| 02/18/2025 | Q4 | $285.7M | $298M | $1.06 | $1.16 | -$0.10 |
| 10/31/2024 | Q3 | $252.2M | $290.1M | $1.05 | $1.00 | $0.05 |
| 08/06/2024 | Q2 | $204.9M | $231.4M | $0.72 | $0.76 | -$0.04 |
| 05/07/2024 | Q1 | $199.6M | $195.9M | $0.60 | $0.70 | -$0.10 |
| 02/20/2024 | Q4 | $231.1M | $230M | $0.65 | $0.83 | -$0.18 |
| 11/06/2023 | Q3 | -- | -- | $0.61 | $0.71 | -$0.10 |
| 08/08/2023 | Q2 | -- | -- | $0.56 | $0.64 | -$0.08 |
| 05/09/2023 | Q1 | -- | -- | $0.29 | $0.48 | -$0.19 |
| 02/21/2023 | Q4 | -- | -- | $0.42 | $0.47 | -$0.05 |
| 11/08/2022 | Q3 | -- | -- | $0.44 | $0.51 | -$0.07 |
| 08/09/2022 | Q2 | -- | -- | $0.16 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | $0.43 | -- | -- |
| 02/22/2022 | Q4 | -- | -- | $0.46 | -- | -- |
| 11/02/2021 | Q3 | -- | -- | $1.48 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | $0.62 | -- | -- |
| 05/10/2021 | Q1 | -- | -- | $0.19 | -- | -- |
| 02/23/2021 | Q4 | -- | -- | $0.50 | -- | -- |
| 11/02/2020 | Q3 | -- | -- | $0.25 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | $0.19 | -- | -- |
| 05/11/2020 | Q1 | -- | -- | -$0.04 | -- | -- |
| 02/24/2020 | Q4 | -- | -- | -$0.24 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$0.17 | -- | -- |
| 08/06/2019 | Q2 | -- | -- | -$0.10 | -- | -- |
| 05/07/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 02/21/2019 | Q4 | -- | -- | -$0.01 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.16 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$0.19 | -- | -- |
| 02/20/2018 | Q4 | -- | -- | $0.85 | -- | -- |
| 11/07/2017 | Q3 | -- | -- | $0.02 | -- | -- |
| 08/08/2017 | Q2 | -- | -- | -$0.23 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.26 | -- | -- |
| 02/28/2017 | Q4 | -- | -- | -$0.21 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.23 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.21 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.16 | -- | -- |
| 02/29/2016 | Q4 | -- | -- | $0.03 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.19 | -- | -- |
Halozyme Therapeutics Earnings Questions
-
How Much did Halozyme Therapeutics Generate in Revenue Last Quarter?
Halozyme Therapeutics reported $264.9M worth of top line sales in its most recent quarter.
-
Did Halozyme Therapeutics Beat Earnings Last Quarter?
Halozyme Therapeutics announced earnings per share of $0.93 which represents a miss of analyst forecast a $0.94 per share.
-
Is Halozyme Therapeutics Profitable?
Halozyme Therapeutics reported $216.5M that represents $1.71 per share over the last quarter.
-
What is the Analyst Consensus for Halozyme Therapeutics EPS Next Year?
Halozyme Therapeutics's earnings are forecast to grow from $3.43 per share to $4.13 per share next year representing an increase of 54.37%.
-
When is Halozyme Therapeutics's Earnings Date?
Halozyme Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
